Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats

Pharmacological Reports

Volumn 57, Issue 6, 2005, Pages 856-860

  Stachowicz, Katarzyna ^a   Kłak, Kinga ^a   Pilc, Andrzej ^a   Chojnacka Wójcik, Ewa ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(S) 3,4 DCPG; Amygdala; Anxiety; Conflict drinking test; Hippocampus; mGlu8 receptor

Indexed keywords

3,4 DICARBOXYPHENYLGLYCINE; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRINKING; HIPPOCAMPUS; MALE; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

EID: 33645675353     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cartmell J, Schoepp DD: Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem, 2000, 75, 889-907.
2. Chojnacka-Wójcik E, Kłodzińska A, Pilc A: Glutamate receptor ligands as anxiolytics. Curr Opin Invest Drugs, 2001, 2, 1112-1119.
3. Conn PJ, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol, 1997, 37, 205-237.
4. Davis M, Rainnie D, Cassell M: Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci, 1994, 17, 208-214.
5. Degroot A, Treit D: Anxiety is functionally segregated within the septo-hippocampal system. Brain Res, 2004, 1001, 60-71.
6. Kullmann DM: Spillover and synaptic cross talk mediated by glutamate and GABA in the mammalian brain. Prog Brain Res, 2000, 125, 339-351.
7. Lee JJ, Jane DE, Croucher MJ: Anticonvulsant dicarboxyphenylglycines differentially modulate excitatory amino, acid release in the rat cerebral cortex. Brain Res, 2003, 977, 119-123.
8. Linden AM, Baez M, Bergeron M, Schoepp DD: Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test. Neuroscience, 2003, 121, 167-178.
9. Linden AM, Johnson BG, Peters SC, Shannon HE, Tian M, Wang Y, Yu JL et al.: Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology, 2002, 43, 251-259.
10. Millan MJ: The neurobiology and control of anxious states. Progr Neurobiol, 2003, 70, 83-244.
11. Moldrich RX, Beart PM, Jane DE, Chapman AG, Meldrum BS: Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology, 2001, 40, 732-735.
12. Pałucha A, Pilc A: On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. Pol J Pharmacol, 2002, 54, 581-586.
13. Pałucha A, Tatarczyńska E, Brański P, Szewczyk B, Wierońska JM, Kłodzńska A, Chojnacka-Wójcik E et al.: Group III mGlu receptor agonists produce anxiolyticand antidepressant-like effects after central administration in rats. Neuropharmacology, 2004, 46, 151-159.
14. Panatier A, Poulain DA, Oliet SHR: Regulation of transmitter release by bigh-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus. Neuropharmacology, 2004, 47, 333-341.
15. Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 2 edn, Academic Press, San Diego, California, 1986.
16. Pin JP, Decolle C, Bessis AS, Acher F: New perspectives for the development of selective metabotropic glutamate receptor ligands. Eur J Pharmacol, 1999, 375, 277-294.
17. Pothecary CA, Jane DE, Salt TE: Reduction of excitatory transmission in the retino-collicular pathway via selective activation of mGlu8 receptors by DCPG. Neuropharmacology, 2002, 43, 231-234.
18. Saugstad JA, Kinzie JM, Shinohara MM, Segerson TP, Westbrook GL: Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Mol Pharmacol, 1997, 51, 119-125.
19. Schmid S, Fendt M: Anxiolytic-like effect of the mGluR8 agonist DCPG in the lateral amygdala in vivo and in vitro. FENS abstr, 2004, 2, A218.12.
20. Schoepp DD: Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther, 2001, 299, 12-20.
21. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ et al.: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci, 1997, 17, 7503-7522.
22. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD: Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov, 2005, 4, 131-144.
23. Tatarczyńska E, Kłodzińska A, Kroczka B, Chojnacka-Wójcik E, Pilc A: The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology, 2001, 158, 94-99.
24. Thomas NK, Clayton P, Jane DE: Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones. Eur J Pharmacol, 1997, 338, 111-116.
25. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE: (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology, 2001, 40, 311-318.
26. Wada E, Shigemoto R, Kinoshita A, Ohishi H, Mizuno N: Metabotropic glutamate receptor subtypes in axon terminals of projection fibers from the main and accessory olfactory bulbs: a light and electron microscopic immunohistochemical study in the rat. J Comp Neurol, 1998, 393, 493-504.
27. Vogel JR, Beer B, Clody DE: A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia (Berlin), 1971, 21, 1-7.
28. Zhai J, Tian MT, Wang Y, Yu JL, Koster A, Baez M, Nisenbaum ES: Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors. Neuropharmacology, 2002, 43, 223-230.